NANOG and hepatocellular carcinoma: In concordance with a previous study in hepatocellular carcinoma (Maehara et al., 2015), we found that KLF5 inhibition dramatically decreased the spheroid growth and downregulated the expression of stem cell markers such as CD44, CD133, NANOG and OCT4 in EOC cells.